$186 Million is the total value of Bill & Melinda Gates Foundation's 11 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VIR | Buy | VIR BIOTECHNOLOGY INC | $40,100,000 | +41.2% | 1,559,142 | +130.0% | 21.56% | +150.2% |
| CVAC | Sell | CUREVAC N V | $33,500,000 | -68.9% | 1,709,781 | -45.5% | 18.01% | -44.8% |
| LUMIRADX LIMITED | $33,400,000 | -32.8% | 5,574,059 | 0.0% | 17.96% | +19.1% | ||
| BNTX | BIONTECH SEsponsored ads | $25,400,000 | -33.7% | 148,674 | 0.0% | 13.66% | +17.5% | |
| EXSCIENTIAads | $22,900,000 | -27.1% | 1,590,909 | 0.0% | 12.31% | +29.2% | ||
| IMCR | IMMUNCORE HLDGS PLCads | $17,200,000 | -69.2% | 576,923 | 0.0% | 9.25% | -45.4% | |
| BFLY | BUTTERFLY NETWORK INC | $4,800,000 | -29.4% | 1,011,003 | 0.0% | 2.58% | +25.1% | |
| BCEL | Sell | ATRECA INC | $4,200,000 | 0.0% | 1,331,358 | -4.7% | 2.26% | +77.2% |
| Buy | SERA PROGNOSTICS INC | $3,000,000 | -44.4% | 799,814 | +2.6% | 1.61% | -1.5% | |
| AMRS | AMYRIS INC | $1,300,000 | -18.8% | 292,398 | 0.0% | 0.70% | +44.1% | |
| ZY | ZYMERGEN INC | $200,000 | -50.0% | 59,970 | 0.0% | 0.11% | -10.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CUREVAC N V | 12 | Q3 2023 | 58.0% |
| VIR BIOTECHNOLOGY INC | 12 | Q3 2023 | 32.0% |
| BIONTECH SE | 12 | Q3 2023 | 35.8% |
| ATRECA INC | 12 | Q3 2023 | 5.3% |
| AMYRIS INC | 12 | Q3 2023 | 1.2% |
| IMMUNCORE HLDGS PLC | 11 | Q3 2023 | 35.7% |
| BUTTERFLY NETWORK INC | 11 | Q3 2023 | 3.8% |
| LUMIRADX LTD | 8 | Q3 2023 | 18.0% |
| EXSCIENTIA | 8 | Q3 2023 | 13.3% |
| ZYMERGEN INC | 6 | Q3 2022 | 0.3% |
View Bill & Melinda Gates Foundation's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LumiraDx Ltd | August 03, 2022 | 19,859,773 | 15.8% |
| Atreca, Inc. | February 16, 2021 | 1,396,644 | 4.7% |
| Liquidia Technologies Inc | February 12, 2020 | 119,678 | 0.5% |
| X4 Pharmaceuticals, Inc | March 15, 2019 | 120,363 | 1.8% |
| Arsanis, Inc. | February 13, 2018 | 722,179 | 5.1% |
View Bill & Melinda Gates Foundation's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| SC 13D | 2022-08-03 |
| SC 13G | 2022-07-15 |
| 13F-HR | 2022-05-13 |
View Bill & Melinda Gates Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.